Hexabromocyclododecane inhibits depolarization-induced increase in intracellular calcium levels and neurotransmitter release in PC12 cells.
about
Policy relevant results from an expert elicitation on the human health risks of decabromodiphenyl ether (decaBDE) and hexabromocyclododecane (HBCD).Selective damage to dopaminergic transporters following exposure to the brominated flame retardant, HBCDDAcute effects of hexabromocyclododecane on Leydig cell cyclic nucleotide signaling and steroidogenesis in vitro.Inhibition of voltage-gated calcium channels as common mode of action for (mixtures of) distinct classes of insecticides.Inhibition of Voltage-Gated Calcium Channels After Subchronic and Repeated Exposure of PC12 Cells to Different Classes of Insecticides.Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltage-Gated Calcium Channel Blockers.Drug discovery models and toxicity testing using embryonic and induced pluripotent stem-cell-derived cardiac and neuronal cellsA comparison of the in vitro cyto- and neurotoxicity of brominated and halogen-free flame retardants: prioritization in search for safe(r) alternatives.Differential effects of 20 non-dioxin-like PCBs on basal and depolarization-evoked intracellular calcium levels in PC12 cells.Hexabromocyclododecane facilitates FSH activation of ERK1/2 and AKT through epidermal growth factor receptor in rat granulosa cells.Scientific Opinion on Hexabromocyclododecanes (HBCDDs) in FoodParallel in vivo and in vitro transcriptomics analysis reveals calcium and zinc signalling in the brain as sensitive targets of HBCD neurotoxicity.Impairment in the mesohippocampal dopamine circuit following exposure to the brominated flame retardant, HBCDD.Halogenated Flame Retardants: Do the Fire Safety Benefits Justify the Risks?
P2860
Q36072551-85A82838-37D5-4FB1-9102-D69192C39268Q36366275-4ED64A40-8C4A-4AE8-AAA3-D9B3DB9ABB48Q36640291-CC518C18-69B5-47A2-AB5C-E46632DA6A3CQ40223384-897944DB-AA15-423C-88E4-5296D993806FQ40723163-A0B1FC85-5205-456F-9241-B5CE14651BD3Q41059066-691EFE33-BD63-45DF-A2B6-5503B3D326D7Q42175982-8434A17F-B766-4176-97D7-78DD33938BFDQ42451957-EE52B83C-570B-4559-BE6F-AF06FCE31BD3Q42499955-706F3E6E-5B58-4D1F-8A6B-B8215D291FF4Q42709187-FECABFC3-4035-4941-ABD5-8826893C78F9Q47150396-1B83109B-62D7-4231-AEC8-3CEA076CB318Q47572573-C9715C4F-5FE8-42FD-8E6C-0AB7764ABEE5Q48302719-C5DF0E48-0D5C-489F-8121-35FDE99356F0Q56431838-BE6CF8EF-9B6D-40F6-A9B9-DF857BC923DE
P2860
Hexabromocyclododecane inhibits depolarization-induced increase in intracellular calcium levels and neurotransmitter release in PC12 cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Hexabromocyclododecane inhibit ...... smitter release in PC12 cells.
@en
Hexabromocyclododecane inhibit ...... smitter release in PC12 cells.
@nl
type
label
Hexabromocyclododecane inhibit ...... smitter release in PC12 cells.
@en
Hexabromocyclododecane inhibit ...... smitter release in PC12 cells.
@nl
prefLabel
Hexabromocyclododecane inhibit ...... smitter release in PC12 cells.
@en
Hexabromocyclododecane inhibit ...... smitter release in PC12 cells.
@nl
P2093
P2860
P356
P1476
Hexabromocyclododecane inhibit ...... smitter release in PC12 cells.
@en
P2093
Aart de Groot
Ake Bergman
Harm J Heusinkveld
Milou M L Dingemans
Remco H S Westerink
P2860
P304
P356
10.1093/TOXSCI/KFN249
P577
2008-12-04T00:00:00Z